Sullivan, Skadden Rep Valeant In $2.6B Skin Care Co. Buy
Canada's Valeant Pharmaceuticals International Inc. continued its recent spate of almost a dozen acquisitions by firming up plans to buy dermatology drugmaker Medicis Pharmaceutical Corp. for $2.6 billion, the pair said...To view the full article, register now.
Already a subscriber? Click here to view full article